Powerful” new treatments for various types of cancer and neurodegenerative disorders, such as Alzheimer’s, Parkinson’s, and ...
Funding from the Hugh and Herbert Hoffman ALS Impact Fund will support eligible clinics nationwide and expand access to life-extending ALS care ...
A Winnipeg scientist developing a new drug candidate for Amyotrophic Lateral Sclerosis has been awarded a national Mitacs ...
A neuromuscular medicine expert and leader in the field of amyotrophic lateral sclerosis (ALS), Jinsy A. Andrews, MD, joins ...
-- Muscular Dystrophy Association Calls FDA Approval of Novartis' Itvisma (onasemnogene abeparvovec-brve) a Major Step Forward for the Spinal Muscular Atrophy Community Mary Fiance, National Vice ...
The latest health news includes FDA chief Richard Pazdur's concerns about new approval processes, a potential ALS treatment breakthrough, UK PM Boris Johnson's handling of COVID-19, Eli Lilly's market ...
This approach has the potential to rejuvenate specific tissues affected by mitochondrial decline," author Gaharwar told ...
Calgary Herald on MSN
'Continue his legacy': Kelsie Snow to talk about her and her late husband Chris's experience with ALS
I've learned how important it is to me to continue his legacy and to continue showing up in this space of the ALS community,' said Kelsie Snow ...
In this interview, Kalpana Barnes highlights how new approach methodologies are addressing the gaps in drug discovery studies ...
Researchers identify neurotoxic protein complex and a pharmacological inhibitor that opens new perspectives for developing ...
From stroke and brain injury, to cognitive impairment and neurological diseases, various conditions can have a profound ...
ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback